Summary
48 / 100 · Bulios Score
What speaks for it
- Revenue grew by 8.4% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- It pays out more in dividends than it earns: 1,610% of profit.
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 7.8% a year over the last 3 years.
- Analysts expect revenue to fall by 8.8% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 243.1 PHP for 1 PHP of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (PHP)
Diluted EPS (PHP)
- Analyst estimate
Revenue grew by 21% a year over 5 years. Over the last 3 years it grew by 8.4% a year. For the next fiscal year analysts expect revenue to fall by 8.8%. Earnings per share fell by 7.8% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 PHP of revenue goes
- Cost of sales 87 PHP
- Sales and administration 5.2 PHP
- Taxes and other 3.0 PHP
- Net profit 4.9 PHP
Net profit, industry median (Chemicals - Specialty) 6.0 PHP
Out of every 100 PHP of revenue, 4.9 PHP is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 9.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 6.62%
- Paid out of profit
- 1,610%
The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.